Control of histamine to promote health and control enterocolitis using probiotic compositions
AssigneeIowa State University Research Foundation, Inc.
InventorMark Lyte
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to use of probiotic compositions and/or histamine degrading enzymes for the control of histamine in a farm production animal, companion animal, aquaculture, or a human, to reduce or eliminate the incidence of necrotizing enterocolitis and/or related inflammatory conditions in the gastrointestinal tract or skin, and behavioral conditions. The disclosure also relates to the probiotic compositions and/or histamine degrading enzymes.
Claims20
A method of controlling histamine production in a subject comprising:
- administering a probiotic composition comprising a Brevibacillus spp. and/or Bacillus spp. and optionally a histamine degrading enzyme to the subject;
- and
- controlling histamine production within the subject.
A method of preventing and/or treating an inflammatory disease and/or an immunological condition mediated by histamine in a subject, comprising:
- administering a probiotic composition comprising a Brevibacillus spp. and/or Bacillus spp. and optionally a histamine degrading enzyme to the subject;
- and
- controlling histamine production within the subject.
A probiotic composition, comprising:
- a therapeutically effective amount of a Brevibacillus spp. and/or Bacillus spp.;
- and
- a therapeutically acceptable excipient, additional functional ingredient, and/or a food/feed component.
Dependencies are inferred from the claim text.